TY - JOUR
T1 - Plant-Based and Animal-Based Low-Carbohydrate Diets and Risk of Hepatocellular Carcinoma Among US Men and Women
AU - Liu, Yue
AU - Yang, Wanshui
AU - VoPham, Trang
AU - Ma, Yanan
AU - Simon, Tracey G.
AU - Gao, Xiang
AU - Chan, Andrew T.
AU - Meyerhardt, Jeffrey A.
AU - Giovannucci, Edward L.
AU - Zhang, Xuehong
N1 - Publisher Copyright:
© 2020 by the American Association for the Study of Liver Diseases.
PY - 2021/1
Y1 - 2021/1
N2 - Background and Aims: Little is known about the role of low-carbohydrate diets (LCDs) in the development of hepatocellular carcinoma (HCC). We prospectively evaluated the associations between plant-based and animal-based LCDs and risk of HCC in the Nurses’ Health Study (NHS) and the Health Professionals Follow-up Study (HPFS). Approach and Results: Dietary intake was assessed every 4 years using validated food frequency questionnaires. Cox proportional hazards regression models were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs). HRs are shown for a 1-standard deviation (SD) increment with variables modeled as continuous. During 3,664,769 person-years of follow-up, there were 156 incident HCC cases. Although there were no associations between overall or animal-based LCD score and risk of HCC, plant-based LCD score was inversely associated with HCC risk (HR, 0.83; 95% CI, 0.70-0.98; Ptrend = 0.03). Carbohydrate intake, especially from refined grains (HR, 1.18; 95% CI, 1.00-1.39; Ptrend = 0.04), was positively, while plant fat (HR, 0.78; 95% CI, 0.65-0.95; Ptrend = 0.01) was inversely associated with HCC risk. Substituting 5% of energy from plant fat and protein for carbohydrate (HR, 0.74; 95% CI, 0.58-0.93; Ptrend = 0.01) or refined grains (HR, 0.70; 95% CI, 0.55-0.90; Ptrend = 0.006) was associated with lower HCC risk. In conclusion, a plant-based LCD and dietary restriction of carbohydrate from refined grains were associated with a lower risk of HCC. Substituting plant fat and protein for carbohydrate, particularly refined grains, may decrease HCC incidence. Conclusions: Our findings support a potential benefit in emphasizing plant sources of fat and protein in the diet for HCC primary prevention; additional studies that carefully consider hepatitis B and C virus infections and chronic liver diseases are needed to confirm our findings.
AB - Background and Aims: Little is known about the role of low-carbohydrate diets (LCDs) in the development of hepatocellular carcinoma (HCC). We prospectively evaluated the associations between plant-based and animal-based LCDs and risk of HCC in the Nurses’ Health Study (NHS) and the Health Professionals Follow-up Study (HPFS). Approach and Results: Dietary intake was assessed every 4 years using validated food frequency questionnaires. Cox proportional hazards regression models were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs). HRs are shown for a 1-standard deviation (SD) increment with variables modeled as continuous. During 3,664,769 person-years of follow-up, there were 156 incident HCC cases. Although there were no associations between overall or animal-based LCD score and risk of HCC, plant-based LCD score was inversely associated with HCC risk (HR, 0.83; 95% CI, 0.70-0.98; Ptrend = 0.03). Carbohydrate intake, especially from refined grains (HR, 1.18; 95% CI, 1.00-1.39; Ptrend = 0.04), was positively, while plant fat (HR, 0.78; 95% CI, 0.65-0.95; Ptrend = 0.01) was inversely associated with HCC risk. Substituting 5% of energy from plant fat and protein for carbohydrate (HR, 0.74; 95% CI, 0.58-0.93; Ptrend = 0.01) or refined grains (HR, 0.70; 95% CI, 0.55-0.90; Ptrend = 0.006) was associated with lower HCC risk. In conclusion, a plant-based LCD and dietary restriction of carbohydrate from refined grains were associated with a lower risk of HCC. Substituting plant fat and protein for carbohydrate, particularly refined grains, may decrease HCC incidence. Conclusions: Our findings support a potential benefit in emphasizing plant sources of fat and protein in the diet for HCC primary prevention; additional studies that carefully consider hepatitis B and C virus infections and chronic liver diseases are needed to confirm our findings.
UR - http://www.scopus.com/inward/record.url?scp=85100564416&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85100564416&partnerID=8YFLogxK
U2 - 10.1002/hep.31251
DO - 10.1002/hep.31251
M3 - Article
C2 - 32222996
AN - SCOPUS:85100564416
SN - 0270-9139
VL - 73
SP - 175
EP - 185
JO - Hepatology
JF - Hepatology
IS - 1
ER -